SOLS Revenue Flow
Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.
- 2026-06-30: Revenue $1.15B; Cost of revenue $778.00M; Research and development $25.00M; Selling, general and administrative $123.00M.
- 2026-03-31: Revenue $991.00M; Cost of revenue $675.00M; Research and development $28.00M; Selling, general and administrative $108.00M.
- 2025-12-31: Revenue $987.00M*; Cost of revenue $729.00M*; Research and development $27.00M*; Selling, general and administrative $112.00M*.
- 2025-09-30: Revenue $969.00M; Cost of revenue $659.00M; Research and development $26.00M; Selling, general and administrative $113.00M.
Consolidation item
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Product or service
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Related Party Transactions By Related Party
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Segment
Separate filed amounts; connecting flows are not established. Components and totals may overlap.
Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.
Historical revenue and expense breakdown
Revenue and expense 3 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.15B | $778.00M | $25.00M | $123.00M | $42.00M | $119.00M |
| 2026-03-31 | $991.00M | $675.00M | $28.00M | $108.00M | $31.00M | $85.00M |
| 2025-12-31 | $987.00M* | $729.00M* | $27.00M* | $112.00M* | $32.00M* | $41.00M* |
| 2025-09-30 | $969.00M | $659.00M | $26.00M | $113.00M | $182.00M | -$35.00M |
| 2025-06-30 | $1.03B | $671.00M | $23.00M | $105.00M | $101.00M | $97.00M |
| 2025-03-31 | $897.00M | $577.00M | $22.00M | $93.00M | $47.00M | $134.00M |
| 2024-09-30 | $907.00M | $575.00M | $21.00M | $107.00M | $49.00M | $152.00M |
Revenue and expense 6 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.14B | $1.45B | $53.00M | $230.00M | $73.00M | $204.00M |
| 2025-06-30 | $1.93B | $1.25B | $45.00M | $198.00M | $148.00M | $231.00M |
Revenue and expense 9 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-09-30 | $2.90B | $1.91B | $70.00M | $309.00M | $330.00M | $196.00M |
| 2024-09-30 | $2.86B | $1.86B | $62.00M | $303.00M | $150.00M | $461.00M |
Revenue and expense 12 month
| Period end | Revenue | Cost of revenue | Research and development | Selling, general and administrative | Income tax | Net income |
|---|---|---|---|---|---|---|
| 2025-12-31 | $3.89B | $2.64B | $97.00M | $421.00M | $362.00M | $237.00M |
| 2024-12-31 | $3.77B | $2.46B | $83.00M | $392.00M | $192.00M | $594.00M |
| 2023-12-31 | $3.65B | $2.37B | $81.00M | $378.00M | $195.00M | $621.00M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BALCHEM CORP (BCPC) | United States | $5.347B | 32.84 |
| Perimeter Solutions, Inc. (PRM) | $4.593B | -17.21 | |
| Ingevity Corp (NGVT) | United States | $2.468B | 47.72 |
| INNOSPEC INC. (IOSP) | United States | $2.380B | 16.37 |
| Chemours Co (CC) | United States | $2.136B | -10.64 |
| OLIN Corp (OLN) | United States | $1.852B | -11.54 |
| Huntsman CORP (HUN) | United States | $1.540B | -6.95 |
| FMC CORP (FMC) | United States | $1.201B | -0.52 |
| Ecovyst Inc. (ECVT) | United States | $1.110B | -22.22 |
| ASCENT INDUSTRIES CO. (ACNT) | United States | $0.132B | -30.55 |